EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy

Muhammad Tufail, Kunxiang Gong, Bushra Ijaz, Harsh Patel, Weng-Onn Lui, Xiumei Wang, Jie Li

Drug Resistance Updates · 2026-03 · 85 · 101355

DOI: 10.1016/j.drup.2026.101355 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2026-03. Verfasst von Muhammad Tufail und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Hospital of Shantou University Medical College, Shantou, China. Electronic address: mtufail0276@gmail.com. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Signal Transduction, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 991 Literaturangaben. Gefördert von: Shantou University Medical College, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmSignal TransductionNeoplasmsAntineoplastic AgentsHumansMolecular Targeted TherapyAnimalsTumor MicroenvironmentEpigenesis, GeneticGene Expression Regulation, NeoplasticNeovascularization, PathologicApoptosisMutationOncogenes

Stichwörter der Autor:innen

Oncogenic signalingcancer resistancehallmarkstherapeutic targetingtumor progression

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Cancer Hospital of Shantou University Medical College, Shantou, China. Electronic address: mtufail0276@gmail.com.
  • Scientific Research Center, First School of Clinical Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China. Electronic address: gkx13265040169@126.com.
  • Applied and Functional Genomics Lab, Centre of Excellence in Molecular Biology, University of the Punjab, 87-West canal Road Thokar Niaz Baig, Lahore, India. Electronic address: bijaz@cemb.edu.pk.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, USA. Electronic address: harsh.patel17@my.stjohns.edu.
  • Department of Oncology-Pathology, Karolinska Institutet, BioClinicum, Karolinska University Hospital, Solna, Sweden. Electronic address: weng-onn.lui@ki.se.
  • Department of Oncology, Affiliated Lianyungang Clinical College of Nantong University, Lianyungang 222006, China. Electronic address: wangxiumei75@163.com.

Förderung

  • Shantou University Medical College
  • National Natural Science Foundation of China

Zitieren

APA

Tufail, M., Gong, K., Ijaz, B., Patel, H., Lui, W. O., Wang, X., & Li, J. (2026). The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy. Drug Resistance Updates, 85, 101355. https://doi.org/10.1016/j.drup.2026.101355

Vancouver

Tufail M, Gong K, Ijaz B, Patel H, Lui WO, Wang X, et al. The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy. Drug Resistance Updates. 2026;85:101355. doi:10.1016/j.drup.2026.101355

BibTeX
@article{Tufail2026,
  author = {Tufail, Muhammad and Gong, Kunxiang and Ijaz, Bushra and Patel, Harsh and Lui, Weng-Onn and Wang, Xiumei and Li, Jie},
  title = {The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {85},
  pages = {101355},
  doi = {10.1016/j.drup.2026.101355}
}
Kostenlos starten →